Western blot analysis Lentivirus-transduced cells were washed twice with https://www.selleckchem.com/products/pnd-1186-vs-4718.html ice-cold PBS and suspended in a lysis buffer (2% Mercaptoethanol, 20% Glycerol, 4% SDS in 100 mM Tris-HCl buffer, pH 6.8). After 15 min of incubation on ice, cells were disrupted by ultrasound on ice. Total cell lysates were then centrifuged (12,000 g, 15 min, 4°C) and the supernatants were employed for further selleck processing. The protein concentration was determined by BCA protein assay
kit. Equal amount of proteins was loaded and separated by SDS-PAGE, and then transferred onto PVDF membrane (Schleicher&Schuell Co., Keene, NH) using an electro-blotting apparatus (Tanon, Shanghai, China). The membrane was blocked with 5% nonfat milk in TBST solution for 1 h at room temperature, and incubated overnight at 4°C with specific antibody to STIM1, p21Waf1/Cip1, STIM2, Orai1, cyclin D1 and CDK4 at the dilution 1:800, 1:1000, 1:800, 1:1000, 1:1500, and 1:1000, respectively. After three washes in TBST solution, the membrane was incubated with horseradish peroxidase-conjugated secondary antibody diluted with TBST solution at room OICR-9429 ic50 temperature for 2 h. The signals of detected proteins were visualized on ECL plus Western blotting detection system (Amersham Biosciences, Inc., Piscataway NJ). GAPDH protein
levels were used as a loading control. MTT cell viability assay and direct cell counting method Cell viability was determined by a colorimetric MTT assay which described previously . Briefly, lentivirus-transduced or TRPC entryway paralysed cells were seeded in 96-well plates at a density of 2 × 103 cells/well. Ten microliters of MTT solution (5 mg/mL) was added into each well once daily for 5 days, and plates were incubated for 4 h at 37°C. After removal of the supernatant, 100 μL of DMSO was added to dissolve the crystals. The absorbance at 490 nm was detected with a microplate reader (Bio-Rad 680). Growth curve was performed according to the absorbance values (A) of 490 nm. On the other hand, direct cell counting method was also used to cross-checking Atezolizumab in vitro the results
of MTT assay. Double target RNAi U251 cells were seeded in 96-well plates at a density of 1 × 104 cells/well. After that, number of cells at 24 h and 48 h after seeding would be counted by blood cell counting plate. Besides, we count 3 wells for reduce error every time point. Growth curve was made according to the average number of cells in 3 wells. BrdU incorporation assay Cell proliferation was also quantified by measuring BrdU incorporation during DNA synthesis using the BrdU Cell Proliferation ELISA kit. The experiment was performed according to the manufacturer’s protocol. Briefly, 10 μL/well of BrdU labeling solution was added to cells at 24 h and 72 h after culture. After overnight incubation, cells were fixed with 200 μL/well of fix solution for 30 min in the dark at room temperature, and then incubated with peroxidase-conjugated anti-BrdU antibody for 90 min in the dark at room temperature.